摘要
目的了解2017年德宏傣族景颇族自治州(简称德宏州)新报告中国籍艾滋病病毒(HIV)感染者的病毒载量基线等情况,为艾滋病的预防和抗病毒治疗研究提供依据。方法对2017年德宏州新报告中国籍HIV感染者进行病毒载量检测,描述比较其人口学特征和病毒载量基线分布。结果 2017年德宏州新报告中国籍HIV感染者383例,其中370例(96.6%)进行病毒载量检测;少数民族占51.9%,小学及以下占52.2%,已婚有配偶占52.2%,异性性传播占88.0%。不同病毒载量除在民族、CD4~+T淋巴细胞(简称CD4细胞)计数中分布有差异外,在其他人口学特征中差异无统计学意义。中位数病毒载量Log_(10)值为4.1(四分位间距:3.3~4.7)拷贝/mL,男性的病毒载量Log_(10)值的中位数为[4.2(四分位间距:3.5~4.8)]拷贝/mL,显著高于女性的[3.9(四分位间距:3.2~4.5)]拷贝/mL。病毒载量与CD4细胞计数呈负相关关系(r~2=-0.30,P<0.001)。6例(1.6%)病毒载量为低于检测限的HIV感染者均为男性,其中4例HIV感染者的CD4细胞计数>500个/μL。结论德宏州新报告HIV感染者的病毒复制水平高,应尽早进行抗病毒治疗以期提高患者生存率。
Objective To determine the demographic characteristics and viral load of Chinese HIV-infected patients in Dehong prefecture, Yunnan province in 2017, and to provide evidence for improving HIV prevention and treatment. Methods The viral load of newly reported Chinese HIV-infected patients was obtained and the demographic characteristics and viral load distribution were analyzed. Results In 2017, 383 Chinese HIV-infected patients were reported, of which 370(96.6%) were tested for viral load; 51.9% were minority; 52.2% had education level of elementary school; 52.2% were married and 88.0% heterosexual. There were significant differences in the distribution of different viral load groups in race and CD4 lymphocytes counts. The median virus load was 4.1(IQR: 3.3-4.7) lg(copies/mL), and the virus load of male[4.2(IQR: 3.5-4.8)] was significantly higher than that of female[3.9(IQR: 3.2-4.5)]. There was a negative correlation between viral load and CD4 lymphocytes counts(r~2=-0.30, P< 0.001). Six(1.6%) HIV-infected patients with viral load TND were male, and 4 patients had CD4 lymphocytes counts>500 cells/μL. Conclusion Dehong newly reported HIV-infected patients have high levels of viral replication, and antiviral therapy should be implemented as soon as possible to improve the survival rate of patients.
引文
[1] Fahey JL,Taylor JM,Manna B,et al.Prognostic significance of plasma markers of immune activation,HIV viral load and CD4 T-cell measurements[J].AIDS,1998,12(13):1581.
[2] 刘佳,李宁,孙定勇,等.2009—2011年河南省部分未治疗艾滋病病毒感染者/艾滋病患者的CD4和病毒载量情况分析[J].现代预防医学,2014,41(11):2074-2078.
[3] 严亚军,桂希恩,荣玉萍,等.HIV感染患者CD4+T淋巴细胞数与病毒载量分析[J].中华医院感染学杂志,2014,24(2):268-270.
[4] 苏洁,韩跃红.云南省推行艾滋病“发现即治疗”的障碍及伦理对策[J].中国医学伦理学,2017,30(12):1460-1465.DOI:10.12026/j.issn.1001-8565.2017.12.03.
[5] 王继宝,陈晓晨,段星,等.云南省德宏傣族景颇族自治州2012—2016年新报告HIV感染者流行病学特征分析[J].中华流行病学杂志,2017,38(10):1372-1375.DOI:10.3760/cma.j.issn.0254-6450.2017.10.015.
[6] Jia M,Wang M,Xiao Y,et al.Estimation of HIV-1 incidence among five focal populations in Dehong,Yunnan:ahard hit area along a major drug trafficking route[J].Bmc Public Health,2010,10(1):180.
[7] 路新利,赵宏儒,李巧敏,等.HIV/AIDS患者病毒载量与CD4细胞数相关性研究[J].现代预防医学,2011,38(20):4256-4257.
[8] Baker JV,Peng G,Rapkin J,et al.CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection[J].AIDS,2008,22(7):841-848.
[9] 杨文杰,安伟锋,马彦民,等.早期抗病毒治疗对艾滋病患者生存状况的影响[J].中华流行病学杂志,2014,35(9):1065-1068.DOI:10.3760/cma.j.issn.0254-6450.2014.09.022.
[10] 荆凡辉,吕玮,李太生.HIV感染者免疫功能重建新视角:CD4/CD8比值[J].中国艾滋病性病,2018,24(6),643-646.DOI:10.13419/j.cnki.aids.2018.06.32.